Evidence supporting the use of: Vitamin E (alpha-tocopheryl acetate)
For the health condition: Dementia

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin E (alpha-tocopheryl acetate) has been investigated as a treatment to support dementia, particularly Alzheimer’s disease, due to its antioxidant properties. The rationale is that oxidative stress is implicated in neuronal damage in neurodegenerative diseases, and vitamin E, as a lipid-soluble antioxidant, could theoretically help protect neuronal membranes from oxidative injury. Several clinical trials have addressed this hypothesis. A notable randomized controlled trial published in 1997 (Sano et al., NEJM) found that high-dose vitamin E (2000 IU/day) modestly delayed functional decline in patients with moderate Alzheimer’s disease. However, subsequent studies, including the large-scale Alzheimer’s Disease Cooperative Study, have shown mixed results: some demonstrated small benefits, while others showed no significant effect on cognition or progression. Meta-analyses also highlight inconsistent findings, and concerns have been raised about potential harm at high doses.

Current clinical guidelines do not recommend vitamin E as a routine treatment for dementia, though it may be considered in some cases. Overall, while there is some scientific evidence supporting a modest benefit of vitamin E in slowing functional decline in Alzheimer’s disease, the effect is small and not universally accepted. Therefore, evidence supporting vitamin E’s use in dementia is limited and only weakly validated by current science.

More about Vitamin E (alpha-tocopheryl acetate)
More about Dementia

Products containing Vitamin E (alpha-tocopheryl acetate)

We currently have no products on Caring Sunshine that contain this ingredient.